Eos Advisory has announced total valuation of £121 million based on latest investment rounds and saw its first two exit events in 2021.

The St Andrews-based investment led a £1.24 million investment into Aberdeen-headquartered R&D firm RAB-Microfluidics in January last year.

In February 2021, Eos announced its first ‘strategic investment partnership’ with US-based Kineticos Life Sciences, to co-invest in early-stage Scottish companies. The venture partnership looks to invest over £10m over the next five years in oncology-focused life sciences ventures.

Sustainable food protein scale-up Enough (previously called 3F BIO), a University of Strathclyde spin-out, secured a $43m Series B round in June last year, one of the largest investment rounds into a Scottish technology company.

In July, RNA and DNA genetic sequencing specialist Wobble Genomics secured a £2.15m. Wobble has developed a range of hardware and software tools that give scientists and clinicians a more detailed picture of our underlying biology.

Eos has also spent 2021 building its team, including the appointment of Chris Brinsmead CBE, a former senior AstraZeneca executive and UK Government adviser, to the firm’s board and Callum Keddie, who previously led a London-based venture capital impact fund, as an Investment Executive.

Recommended

• Opinion | The cyber skills shortage may not be quite as it seems
• Robot performs surgery on throat tumour in Scottish first
• Scots firm Earth Blox unveils no-code solution to satellite data

Commenting on the news, Andrew McNeill, Managing Partner, Eos Advisory, said: “Over the past twelve months, Eos Advisory has seen significant growth both in our portfolio and in our core business.

“We already had a strong track record for due diligence and supporting our portfolio, but we have found that better communicating our focus and process as impact investors has really widened our network of investors and our opportunities.

“Our modus operandi is to continue supporting our companies post-investment and helping them to grow. On the investor side, we have expanded the investor base outside Scotland, especially across the UK and North America. 2022 is going to be another exciting year and we have a number of milestone announcements in the pipeline.”

Mark Beaumont, Partner, Eos Advisory, said: “The Eos Syndicate continues to be a collective of very active investors in innovation that has a positive impact in the world, emanating mainly from Scottish universities, and the addition of our EIS Innovation Fund in 2021 has allowed a new way for us to support these businesses.

“In 2022, we aim to continue this growth pattern with a second raise of our EIS Innovation Fund.”

Get the latest news from DIGIT direct to your inbox 

Our newsletter covers the latest technology and IT news from Scotland and beyond, as well as in-depth features and exclusive interviews with leading figures and rising stars. 

We will keep you up to date on the pivotal issues impacting the sector and let you know about key upcoming events to ensure that you don’t miss out on what’s going on across the Scottish tech community. 

To subscribe, click here.